Robert R Lavieri

Title: Innovations in Tumor Metastasis Inhibition by Robert R. Lavieri

Introduction

Robert R. Lavieri is an accomplished inventor based in Nashville, TN. He has made significant contributions to the field of cancer research, particularly in the area of tumor metastasis. His innovative work focuses on methods to inhibit the spread of cancer cells, which is a critical challenge in oncology.

Latest Patents

Lavieri holds a patent for "Methods of inhibiting tumor metastasis - Thromboxane A2 receptor antagonists." This patent describes how thromboxane A2 receptor antagonists, such as ifetroban, can inhibit solid tumor metastasis. The findings indicate that the formation of both surface and microscopic lung metastases can be effectively inhibited. Importantly, these antagonists can disrupt the tumor metastasis process without adversely affecting the growth or development of the primary tumor. He has 1 patent to his name.

Career Highlights

Lavieri is affiliated with Vanderbilt University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential to improve cancer treatment outcomes and enhance patient care.

Collaborations

Lavieri collaborates with fellow researcher Jill M. Pulley, working together to advance their understanding of tumor biology and develop innovative therapeutic strategies.

Conclusion

Robert R. Lavieri's contributions to cancer research through his patent on tumor metastasis inhibition highlight the importance of innovative approaches in the fight against cancer. His work at Vanderbilt University continues to pave the way for future advancements in oncology.